Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.955 USD | -1.26% | -2.48% | -0.51% |
05-09 | Transcript : ProQR Therapeutics N.V. - Special Call | |
05-09 | ProQR Therapeutics N.V. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.51% | 161M | |
+5.43% | 109B | |
+11.07% | 105B | |
-0.38% | 22.25B | |
-12.19% | 22.09B | |
-7.66% | 18.68B | |
-36.52% | 17.58B | |
-10.41% | 16.85B | |
+2.85% | 13.76B | |
+35.12% | 12.46B |
- Stock Market
- Equities
- PRQR Stock
- News ProQR Therapeutics N.V.
- Chardan Research Downgrades ProQR Therapeutics to Neutral From Buy on Further Restructuring, Wind-Down of Inherited Retinal Disease Programs; $2 Price Target Removed